We have developed a rapid, automated nucleic acid purification device in a single cartridge containing silica-coated magnetic beads. We succeeded in extracting the matrix protein gene of influenza A virus from pharyngeal swab samples within 3 min. The device will be widely applicable to detect a specific gene from the various samples for clinical diagnosis and genetic research.
Introduction
Diagnostic methods for detecting and purifying a specific gene have been widely and practically applicable in various fields, including medicine. The genetic tests are particularly important for rapid diagnosis of infectious diseases in a patient. Polymerase chain reaction (PCR), a nucleic acid amplification method, is one of the most sensitive methods for detecting target genes with low concentration. 1 However, purification of nucleic acids is necessary for PCR, and it requires much time and a high level of technical skills. Therefore, a rapid, and automated device for extracting nucleic acids is desired and has been a focus of much research. [2] [3] [4] In viral and bacterial infections, PCR is an essential diagnostic method to ensure that treatment is started at the earliest for a patient. 5, 6 However, PCR has been available only in the centralized laboratories of relatively large hospitals because of the requirement of technicians with experience and specialized skills. Among the steps of PCR, extraction and purification of nucleic acids takes much time, and contamination of unexpected nucleic acids often occur due to repetition of manual operations. Therefore, a rapid and automated device for extracting DNA or RNA is desirable, and it will save time and efforts with no requirement for technical skills. The device will be able to purify nucleic acids in a cartridge, in which all processes including extraction, liquid transport, mixing, and analysis will occur.
Many studies have reported on rapid nucleic acid extraction using microfluidic systems. [7] [8] [9] [10] In these studies, solid phase extraction achieved nucleic acid extraction in approximately 5 -10 min using a microfluidic system. However, in these nucleic acid extraction processes, a liquid transfer pump and valve or centrifugation is necessary. The usefulness of magnetic beads in the microfluidics has already been reported in the bioassay field. [9] [10] [11] [12] [13] Magnetic beads are easily controlled from the outside of the camber, and in microfluidics, they are indirectly transferred between several reagents for lysing, extracting, and washing. We also used a combination of superparamagnetic beads and magnetic force for purifying nucleic acids.
In this study, we developed an integrated system that automatically performs cell lysis and purification of nucleic acids (extraction and washing) in a single cartridge. No external pumps or valves are necessary for our system. All processes from loading samples to purifying nucleic acid are completed within 3 min. This system has many advantages for molecular analyses and diagnostic applications.
Experimental

Cartridge and device construction
The cartridge comprises a bottle and a capillary tube (Fig. 1a) . Magnetic beads attach nucleic acids on themselves in the bottle, and the beads with nucleic acids are purified by passing through several reagents in the capillary tube with 1-mm diameter. The bottle contains 493 μL of lysis and binding solution and 2 μL of magnetic beads (Toyobo Co., Ltd., Osaka, Japan). The capillary tube is equipped with 280, 22, and 4 μL of washing solution I, washing solution II, and elution (reaction) solution, respectively (Toyobo Co., Ltd.), which are separated by 2CS silicone oil plugs. The magnetic beads are controlled by the external magnetic control system, which consists of two magnetic components to transfer the magnetic beads longitudinally and horizontally (Fig. 1b) . Nucleic acids are eluted from magnetic beads in the capillary tube.
Operation
The external magnets transfer the magnetic beads with nucleic acids through the washing and reaction solutions in the capillary tube. The beads are horizontally vibrated in a front-to-back motion by a pair of magnets set at both sides of the capillary tube (Figs. 2e and 2f ). To optimize the motion of the magnetic beads for efficient extraction, we evaluated both the transport speed and the vibration frequency. As a result, we used transport speed of 2 mm s -1 and a vibration frequency of 4 Hz in our study. The magnetic beads attached with nucleic acids are washed in the washing solutions and are eluted in the reaction solution (Fig. 2b) . Next, the purified nucleic acid solution is ejected into the capillary tube by pressing the bottle (Fig. 2d) .
System testing and validation
To test the RNA recovery efficiency of our system, the Influenza A RNA (Vircell, Granada, Spain) was used. We added 3 × 10 4 copies of the Influenza A RNA to the sample solution. To test the purification efficiency of our system, we used clinical samples containing influenza A virus. The pharyngeal swab samples were obtained as the remaining samples after the clinical examination by immunochromatography with commercial antigen detection kits. Nucleic acid was purified by using a Nucleic Acid Purification Kit MagExtractor TM -Viral RNA-(Toyobo Co., Ltd., Osaka, Japan). Five microliters of the sample solution and 2 μL of magnetic beads were added to the bottle with 493 μL of lysis and binding solution (Fig. 2a) . The bottle was shaken for 30 s to allow for the binding of nucleic acids to the magnetic beads. The magnetic control system horizontally vibrated the magnetic beads and transferred them to the capillary tube. All extraction and purification steps were automatically performed (Fig. 2) .
To assess the RNA recovery efficiency or the purification efficiency of the device, reverse transcription (RT)-PCR was performed with StepOnePlusTM (Life Technologies Corporation, Carlsbad, CA, USA). The primers and duallabeled probes for universal influenza A were designed according to a Centers for Disease Control and Prevention (CDC) protocol. 14 The one-step real-time RT-PCR reaction mixture contained RNA, SuperScript III/Platinum Taq Mix (Life Technologies, Grand Island, NY, USA), 1 × reaction mix with ROX (Life Technologies), 0.8 μmol/L of each primer, and 0.2 μmol/L of dual-labeled probe in a total of 10 μL. Of the reaction mixture, 10 μL was used for conventional PCR. The reaction conditions were as follows: 50 C for 30 min for RT, 95 C for 2 min for RT inactivation, and 50 cycles at 95 C for 15 s and 55 C for 30 s. PCR products were confirmed by 4% agarose gel electrophoresis. All experimental procedures were performed in accordance with the regulations of the institutional review board of Shinshu University and Seiko Epson.
To evaluate the ability of the automated nucleic acid purification device, its RNA recovery efficiency or its purification efficiency was compared with that of a standard protocol using the same commercial purification reagent (Nucleic Acid Purification Kit MagExtractor TM -Viral RNA-, Toyobo). As the standard protocol, the purification procedure was performed according to the manufacturer's instructions for the reagent. The purified RNA was tested by quantitative RT-PCR using StepOnePlus TM . The same volume of purified RNA was added to the quantitative RT-PCR mixture from the elution solution in both methods. Reaction solutions after RT-PCR were collected from the reaction tube and separated by gel electrophoresis. 
Results and Discussion
The standard protocol needed 25 μL of magnetic beads and 27.5 μL of elution solution. Conversely, our device needed only 2 μL of magnetic beads and 4 μL of elution solution. The results of the RNA recovery efficiency and the purification efficiency are shown in Fig. 3 . Both the RNA recovery efficiency and the purification efficiency of our device were the same as those of the standard method. However, it took only 3 min to purify nucleic acids compared with 30 min by the standard method. The amplified products of the reaction solutions after RT-PCR were of the expected length, and no byproducts were observed (data not shown).
Our rapid and automated nucleic acid purification device purified nucleic acids from the crude clinical samples within less than 3 min. All processes of nucleic acid purification, which included extraction and washing of the nucleic acids, could be automatically completed in a disposable cartridge. Therefore, no specific training for gene handling is required to perform nucleic acid extraction. Using our new device for purifying nucleic acids, rapid PCR tests can be made available in the outpatient clinics as well as relatively large hospitals, and it may replace immunochromatography tests to detect many microorganisms, such as influenza virus, adenovirus, α-streptococcus, and mycoplasma.
Automated and rapid nucleic acid purification system
Using the magnetic control system, all process of purifying nucleic acids can be performed automatically (Fig. 2) . No external pumps or valves are necessary for our compact system. The disposable cartridge contains reagents separated by oil plugs in a capillary tube needed for purifying nucleic acids. Appropriate doses of the reagents are prepacked in the order for a given assay. A magnetic control system can move the magnetic beads through the cartridge as an examiner likes, and an embedded microprocessor can change movement of the beads required for each assay. Our device could purify nucleic acids from the crude clinical samples within 3 min, whereas the standard method took 30 min. Using the magnetic beads, efficiency of extraction, washing and elution of nucleic acids may increase.
Potential applications of our device
Our nucleic acid purification system simplifies DNA or RNA extraction to an insertion-and-purification process without operator intervention and other laboratory equipment. The amplicon cross-contamination is prevented because all purifying steps can occur in a disposable cartridge. Using our new device, any technician with minimum training for genomic examination can rapidly purify nucleic acids without contamination in nonlaboratory environments. If PCR is automatically completed within 10 min and costs the same as immunochromatographic tests, the former will replace the latter because of high sensitivity and specificity. The rapid and correct diagnosis for infectious diseases in a short span of time facilitates early start of the treatment. In addition, our device has a variety of potential applications and can purify nucleic acid from all biological materials including tissue fragments and blood in addition to the microorganisms. Our device will improve genetic testing in not only medical diagnostics but also other fields.
